LAT and eye infection: At a dose of 1 × 103 pfu/eye, 9 of 16 of IFNαβR−/− mice infected with LAT-plus survived ocular infection (56% survival), while only 1 of 16 IFNαβR−/− mice infected with LAT-minus virus survived ocular infection (6% survival).